Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor-Reference-Cited by-同舟云学术

Paclitaxel, ifosfamide, and cisplatin (TIP) as salvage and consolidation chemotherapy for advanced germ cell tumor

Published:2014-07-26 Issue:1 Volume:141 Page:127-133
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Kurobe Masahiro,Kawai Koji,Oikawa Takehiro,Ichioka Daishi,Kandori Shuya,Takaoka Ei-ichirou,Kojima Takahiro,Joraku Akira,Suetomi Takahiro,Miyazaki Jun,Nishiyama Hiroyuki

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/article/10.1007/s00432-014-1760-x/fulltext.html

Reference18 articles.

1. De Wit R, Skoneczna I, Daugaard G et al (2012) Randomized phase III study comparing paclitaxel-bleomycin, eoposide, and cisplatin (BEP) to standard BEP in intermediate prognosis germ cell cancer:intergroup study of EORTC 30983. J Clin Oncol 30:792–799

2. Einhorn LH, Williams SD, Chamness A et al (2007) High-dose chemotherapy and stem-cell rescue for metastatic germ-cell tumors. N Engl J Med 357:340–348

3. International Prognostic Factor Study Group (1997) International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. J Clin Oncol 15:594–603

4. Kawai K, Miyazaki J, Tsukamoto S et al (2003) Paclitaxel, ifosfamide and cisplatin regimen is feasible for Japanese patients with advanced germ cell cancer. Jpn J Clin Oncol 33:127–131

5. Kollmannsberger C, Beyer J, Liersch R et al (2004) Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group. J Clin Oncol 22:108–114

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant role of Salvia miltiorrhiza bunge in cancer chemotherapy: A review of its bioactive components, health-promotion effect and mechanisms;Journal of Ethnopharmacology;2024-01

2. Case of the Month from University of Melbourne, Australia: refractory chyle leak after retroperitoneal lymph node dissection with updated algorithm;BJU International;2023-10-03

3. The Efficacy and Safety of Irinotecan, Paclitaxel and Oxaliplatin (IPO) Regimen as Salvage in Relapsed/Refractory Ovarian Germ Cell Tumors;Indian Journal of Gynecologic Oncology;2022-11-28

4. Relapsed and refractory yolk sac tumor of the peritoneum (mesentery): A case report and literature review;Frontiers in Oncology;2022-08-09

5. Platinum-Based Chemotherapy ‘Rechallenge’ in Advanced Non-ovarian Solid Malignancies;Clinical Oncology;2022-08